Robert Hazlett

Stock Analyst at BTIG

(2.52)
# 697
Out of 5,271 analysts
47
Total ratings
36.00%
Success rate
110.83%
Average return
22 Stocks
Name Action Price Target Current % Upside Ratings Updated
Aura Biosciences
Maintains: Strong Buy
21 24
7.21 232.87% 3 Oct 18, 2024
Nektar Therapeutics
Assumes: Buy
4
0.81 393.83% 2 Sep 30, 2024
Rani Therapeutics Hl...
Maintains: Strong Buy
7 14
1.46 858.9% 2 May 9, 2024
Aravive
Downgrades: Neutral
n/a
n/a n/a 2 Aug 3, 2023
Seelos Therapeutics
Maintains: Buy
42240 15360
n/a n/a 5 May 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
24 20
0.2 9900% 1 Feb 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
62 98
127.09 -22.89% 2 Dec 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
96 60
5.54 983.03% 3 Oct 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
1710 1440
n/a n/a 1 Sep 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
522 216
n/a n/a 3 Aug 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Feb 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
15
0.04 37400% 3 Dec 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
7
n/a n/a 1 Aug 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
63
3.69 1607.32% 1 May 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
280
0.03 933233.33% 2 Apr 16, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
29
14.38 101.67% 4 Feb 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
80 40
131.27 -69.53% 2 Nov 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
26000
3.25 799900% 1 Sep 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
26 6
1.8 233.33% 2 Sep 4, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
18 27
10.85 148.85% 2 Oct 16, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
32
n/a n/a 1 Aug 31, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
13
n/a n/a 1 Apr 21, 2017